Diabetes-caused liver disease

It was published in the Journal of the American Diabetes Association "Diabetes Care" on an academic paper, in a variety of oral hypoglycemic agents treatment of patients with type 2 diabetes, all kinds of liver disease rate significantly higher. In this study, British researchers to 44,406 a variety of oral hypoglycemic agents in the treatment of type 2 Diabetic patients with a follow-up investigation. The results showed that 605 inspections identified by lesions in the liver, due to Here, the liver disease incidence rate of 53.2 / 10,000 years. This occurred in 605 patients with liver disease , 186 asymptomatic patients, had a mild liver damage; 249 patients with a risk of Transfer; 113 patients there are other causes of liver damage. Of these, 57 patients with type 2 diabetes Liver disease may be caused by their use of drug-induced, and therefore, drug-induced liver disease incidence rate of 5.0/10000 years. 57 occurred in the liver of the cases, 11 cases are caused by other drugs, eight patients with liver problems from diabetes caused by fatty liver caused by the remaining patients, leading to liver disease causes ominous. In this 57 patients, 51 patients with oral hypoglycemic agents to continue treatment. There are two patients with liver problems can not be sure of the ground caused by oral hypoglycemic agents. Therefore, these studies show that oral hypoglycemic agents in the treatment of patients with type 2 diabetes, in the Types of liver diseases pose a higher risk, although not all of these liver disease is caused by oral hypoglycemic agents, but in patients with type 2 diabetes, liver and kidney toxicity choose a lower oral hypoglycemic agents is very important The.